PCL/HAP Composite

● Product Description

PCL/HAP Composite (Polycaprolactone/Hydroxyapatite) is a high-performance medical-grade nanocomposite fabricated by blending Polycaprolactone (PCL) with Hydroxyapatite (HAP). This composite integrates the superior processability of PCL and the bioactivity of HAP:

•PCL contributes excellent flexibility, extensibility, and shape memory;

•HAP provides osteoconductivity and bone-bonding capacity, containing Ca and P elements essential for osteoblast growth and differentiation;

•The composite enhances mechanical properties and osteogenic activity, strengthening osteoconduction and bone regeneration functions. 

● Specifications

Appearance: Granules, powder, or blocks; customizable forms available upon request

Solubility: Insoluble in water; soluble in polar organic solvents

FE-SEM images of the highly microporous PCL/HAP composite structures produced with HA content of 10 wt%

● Product List

•Store sealed in a dry, low-temperature (-20℃) environment; seal tightly with a sealing machine.

•Allow to reach room temperature before use to avoid condensation-induced degradation; maintain a clean environment.

•Keep away from water, acids, alkalis, alcohols, and other substances that may cause degradation.

1. Materials 2017, 10(10), 1123; https://doi.org/10.3390/ma101011232.

2. J Mater Sci: Mater Med 32, 93 (2021). https://doi.org/10.1007/s10856-021-06564-0